Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) dropped 5.5% during trading on Wednesday . The stock traded as low as $3.24 and last traded at $3.25, with a volume of 114,507 shares. The stock had previously closed at $3.44.

Separately, Maxim Group set a $6.00 price objective on shares of Onconova Therapeutics and gave the company a “buy” rating in a report on Thursday, August 11th.

The firm’s market cap is $18.77 million. The stock’s 50 day moving average price is $3.77 and its 200-day moving average price is $4.67.

Onconova Therapeutics (NASDAQ:ONTX) last released its quarterly earnings data on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share (EPS) for the quarter. The firm earned $2.25 million during the quarter. Analysts predict that Onconova Therapeutics Inc. will post ($2.15) EPS for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.